Drugmaker Regeneron Pharmaceuticals has announced plans to acquire 23andMe Holding for $256 million through a bankruptcy auction. The purchase, set to conclude in the third quarter of the year, comes
All posts tagged in genetic testing
3Articles
23andMe, the prominent California-based genetic testing company, has filed for Chapter 11 bankruptcy protection in the United States. The move comes as the firm seeks to secure a buyer and
The recent alignment of seven major planets over Britain coincided with promising developments in the field of genetics, particularly for UK-based Genomics, a genetic analytics firm spearheading a transformative approach
